ClinicalTrials.Veeva

Menu

Investigations on the Effect of Kale on the Lipid Status (HypocholKale)

U

University of Jena

Status

Unknown

Conditions

Effects of Kale Ingredients on Lipid Status Parameter

Treatments

Dietary Supplement: Kale Preparation "Kale Extract"
Dietary Supplement: Kale Preparation "Kale Powder"
Dietary Supplement: Kale Preparation "Flavonoid Extract"
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03545555
AGBAP2018-1

Details and patient eligibility

About

This intervention study investigates the effects of various kale preparations (dietary supplements) on lipid status parameters. Within the study period of 8 weeks, three blood withdrawals are planned (week 0, 4 and 8) for the volunteers. Lipid status parameters (total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides) will be determined in blood. There is a correlation between contents of LDL cholesterol, total cholesterol and triacylglycerides and the risk for cardiovascular diseases (CVD). In contrast, a high content of HDL cholesterol is correlated with a lower risk for CVD. In addition, the contents of apolipoprotein A1 and apolipoprotein B will be analysed.

Enrollment

40 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • total cholesterol > 200 mg/dl

Exclusion criteria

  • LDL cholesterol < 130 mg/dl
  • medication to lower blood lipids
  • genetically based hypercholesterolemia

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 4 patient groups, including a placebo group

Kale Powder
Experimental group
Description:
5 capsules with kale preparation "kale powder" per day for 8 weeks
Treatment:
Dietary Supplement: Kale Preparation "Kale Powder"
Kale Extract
Experimental group
Description:
5 capsules with kale preparation "kale extract" per day for 8 weeks
Treatment:
Dietary Supplement: Kale Preparation "Kale Extract"
Flavonoid Extract
Experimental group
Description:
5 capsules with kale preparation "flavonoid extract" (from kale) per day for 8 weeks
Treatment:
Dietary Supplement: Kale Preparation "Flavonoid Extract"
Placebo
Placebo Comparator group
Description:
5 capsules with "placebo" per day for 8 weeks
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Volker Böhm, PD Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems